Idexx Laboratories
As on 21 Apr, 2026 | 01:29 IST
| Open | 583.12 |
| Previous Close | 589.25 |
| Beta | 0.29 |
| High | 590.09 |
| Low | 579.97 |
| TTM EPS See historical trend | 12.68(+12.71% YoY) |
| 52 Week High | 769.98 |
| 52 Week Low | 402.85 |
| TTM PE See historical trend | 45.98(Average PE) |
| Mkt. Cap ($ Billion) | 48.43 |
| Dividend Yield | -- |
Advanced Chart
*Delayed by 20 seconds
MC Technicals
| Days | |
|---|---|
| 5 | 581.34 |
| 10 | 579.51 |
| 20 | 574.07 |
| 50 | 601.91 |
| 100 | 651.21 |
| 200 | 637.36 |
Returns
| 1 Week | 1.56% | |
| 1 Month | 1.12% | |
| 3 Months | -14.98% | |
| YTD | -13.80% | |
| 1 Year | 41.59% | |
| 3 Years | 18.84% |
Financialsin million $
Peers
| Name | Price ($) | Change% | M.Cap(Billion $) | TTM PE | TTM EPS | DY | 52 wk high/low | Technical Rating | |
|---|---|---|---|---|---|---|---|---|---|
| Thermo Fisher Scientific | 526.02 | -0.11 | 200.70 | 23.01 | 22.87 | 0.30 | 643.99/385.72 | 10.89 | Very Bearish |
| Abbott | 96.00 | -0.84 | 166.53 | 18.43 | 5.21 | 2.38 | 139.02/93.95 | -9.05 | Neutral |
| Intuitive Surgical | 465.60 | -0.77 | 165.02 | 52.13 | 8.93 | -- | 603.70/427.84 | -2.61 | Very Bearish |
| Zoetis | 122.64 | 0.21 | 56.18 | 19.11 | 6.42 | 1.61 | 172.02/113.31 | 6.21 | Very Bearish |
| Idexx Laboratories | 583.06 | -1.05 | 48.43 | 45.98 | 12.68 | -- | 769.98/402.85 | 1.12 | Very Bullish |
Market news
- Wall St ends mixed, notches weekly gains as investors parse Middle East negotiationsApril 11, 2026 8:53 AM
- Wall Street skids as Middle East turmoil fans inflation fearMarch 21, 2026 9:02 AM
- Wall Street closes lower, posts weekly loss as war on Iran fuels inflation worriesMarch 14, 2026 8:59 AM
- US stocks close down as oil spikes 12%, job market weakensMarch 7, 2026 9:27 AM
About the company
IDEXX Laboratories, Inc. develops, manufactures and distributes products and provides services for the companion animal veterinary, livestock and poultry, dairy and water testing markets. It also sells a line of portable electrolytes and blood gas analyzers used in the human diagnostics market. Its segments include Companion Animal Group (CAG), Water quality products (Water), and Livestock, Poultry and Dairy (LPD). The CAG segment CAG develops, designs, manufactures, and distributes products and performs services for veterinarians and the biomedical analytics market, primarily related to diagnostics and information management. The Water segment develops, designs, manufactures, and distributes a range of products used in the detection of various microbiological parameters in water. The LPD segment develops, designs, manufactures, and distributes diagnostic tests and related instrumentation and performs services that are used to manage the health status of livestock and poultry.